Microdose GnRH agonist flare-up versus ultrashort GnRH agonist combined with fixed GnRH antagonist in poor responders of assisted reproductive techniques cycles

International Journal of Fertility and Sterility

Volumn 6, Issue 4, 2013, Pages 266-271

  Eftekhar, Maryam ^a   Mohammadian, Farnaz ^a,b   Yousefnejad, Fariba ^a   Khani, Parisa ^a  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Assisted reproductive technology; GnRH agonist; GnRH antagonist; Poor responder

Indexed keywords

BUSERELIN; CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

ADULT; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; EMBRYO TRANSFER; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; OOCYTE RETRIEVAL; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL; TRANSVAGINAL ECHOGRAPHY;

EID: 84874773734     PISSN: 2008076X     EISSN: 20080778     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Garcia-Velasco JA, Isaza V, Requena A, Martinez-Salazar FJ, Landazabal A, Remohi J, et al. High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized, controlled trial. Hum Reprod. 2000; 15(11): 2292-2296.
2. Kucuk T, Kozinoglu H, Kaba A. Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response: a prospective, randomized, clinical trial. J Assist Reprod Genet. 2008; 25(4): 123-127.
3. Shahrokh Tehraninejad E, Fazel A, Samiei A, Rashidi B, Kiani K. Flexible, Multi-dose GnRH Antagonist versus Long GnRH Agonist Protocol in Poor Responders: A Randomized Controlled Trial. Int J Fertil Stril. 2009; 2 (4): 165-168.
4. Surrey ES, Schoolcraft WB. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil Steril. 2000; 73(4): 667-676.
5. Tazegül A, Görkemli H, Özdemir S, Aktan TM. Comparison of multiple dose GnRH antagonist and minidose long agonist protocols in poor responders undergoing in vitro fertilization: a randomized controlled trial. Arch Gynecol Obstet. 2008; 278(5): 467-472.
6. Tarlatzis BC, Zepiridis L, Grimbizis G, Bontis J. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update. 2003; 9(1): 61-76.
7. Mahutte NG, Arici A. Poor responders: does the protocol make a difference? Curr Opin Obstet Gynecol. 2002;14(3): 275-281.
8. Vollenhoven B, Osianlis T, Catt J. Is there an ideal stimulation regimen for IVF for poor responders and does it change with age? J Assist Reprod Genet. 2008; 25(11-12): 523-529.
9. Fabregues F, Penarrubia J, Creus M, Manau D, Casals G, Carmona F, et al. Transdermal testosterone may improve ovarian response to gonadotrophins in low-responder IVF patients: a randomized, clinical trial. Hum Reprod. 2009; 24(2): 349-359.
10. Goswami SK, Das T, Chattopadhyay R, Sawhney V, Kumar J, Chaudhury K, et al. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report. Hum Reprod. 2004; 19(9): 2031-2035.
11. Demirol A, Gurgan T. Comparison of microdose flare-up and antagonist multiple-dose protocols for poor-responder patients: a randomized study. Fertil Steril. 2009; 92(2): 481-485.
12. Davar R, Aflatoonian A, Asgharnia M. Clinical Effects of a Microdose GnRH Agonist Flare Regimen Administered to Poor Responders Undergoing ART Cycles. Acta Medica Iranica. 2009; 47(4): 263-267.
13. Padilla SL, Dugan K, Maruschak V, Shalika S, Smith RD. Use of the flare-up protocol with high dose human follicle stimulating hormone and human menopausal gonadotropins for in vitro fertilization in poor responders. Fertil Steril. 1996; 65(4):796-799.
14. Surrey E S. Management of the poor responder: the role of GnRH agonists and antagonists. J Assist Reprod Genet. 2007; 24(12): 613-619.
15. Diedrich K, Diedrich C, Santos E, Zoll C, Al-Hasani S, Reissmann T, et al. Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum Reprod. 1994; 9(5): 788-791.
16. Lainas TG, Sfontouris IA, Papanikolaou EG, Zorzovilis JZ, Petsas GK, Lainas GT, et al. Flexible GnRH antagonist versus flare-up GnRH agonist protocol in poor responders treated by IVF: a randomized controlled trial. Hum Reprod. 2008; 23(6): 1355-1358.
17. Pandian Z, McTavish AR, Aucott L, Hamilton MP, Bhattacharya S. Interventions for 'poor responders' to controlled ovarian hyper stimulation (COH) in invitro fertilisation (IVF). Cochrane Data base Syst Rev.2010;1: CD004379.
18. Akman MA, Erden HF, Tosun SB, Bayazit N, Aksoy E, Bahceci M. Addition of GnRH antagonist in cycles of poor responders undergoing IVF. Hum Reprod. 2000; 15(10): 2145-2147.
19. Berker B, Duvan Ci, Kaya C, Aytaç R, Şatiroǧlu H. Comparison of the ultrashort gonadotropin-releasing hormone agonist-antagonist protocol with microdose flare-up protocol in poor responders: a preliminary study. J Turkish German Gynecol Assoc. 2010; 11 (4): 187-193.
20. Griesinger G, Diedrich K, Tarlatzis BC, Kolibianakis EM. GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis. Reprod Biomed Online. 2006;13(5):628-638.
21. Kahraman K, Berker B, Atabekoglu CS, Sonmezer M, Cetinkaya E, Aytac R, et al. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle. Fertil Steril. 2009; 91(6): 2437-2444.
22. Surrey ES. Management of the poor responder: the role of GnRH agonists and antagonists. J Assist Reprod Genet. 2007;24(12): 613-619.
23. Scott RT, Navot D. Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization. Fertil Steril. 1994; 61(5): 880-885.
24. Akman MA, Erden HF, Tosun SB, Bayazit N, Aksoy E, Bahceci M. Addition of GnRH antagonist in cycles of poor responders undergoing IVF. Hum Reprod 2000; 15(10): 2145-2147.
25. Craft I, Gorgy A, Hill J, Menon D, Podsiadly B. Will GnRH antagonists provide new hope for patients considered "difficult responders" to GnRH agonist protocols? Hum Reprod 1999 14 (12): 2959-2962.
26. Berger BM, Ezcurra D, Alper MM. The agonist-antagonist protocol: anovel protocol for treating the poor responder. Fertil steril. 2004; 82 Suppl 2: S126.
27. Erden HF, Akman MA, Bayazit N, Bahceci M. Efficacy of a new agonist-antagonist protocol compared to mcrodose flare-up in poor responder IVF patients. Fertil steril. 2005; 84 Suppl 1): S128-S129.
28. Orvieto R, Kruchkovich J, Rabinson J, Zohav E, Anteby EY, Meltcer S. Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programs. Fertil Steril. 2008; 90(1): 228-230.
29. Nikolettos N, Al-Hasani S, Felberbaum R, Demirel LC, Kupker W, Montzka P, et al. Gonadotropin-releasing hormone antagonist protocol: a novel method of ovarian stimulation in poor responders. Eur J Obstet Reprod Biol. 2001;97(2):202-207.
30. Akman MA, Erden HF, Tosun SB, Bayazit N, Aksoy E, Bahceci M. Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial. Hum Reprod. 2001;16(5):868-670.